Literature DB >> 32541997

[Inflammation grading and sialoendoscopic treatment of 131I radioiodine-induced sialadenitis].

X Li1, J Z Su1, Y Y Zhang1, L Q Zhang2, Y Q Zhang2, D G Liu2, G Y Yu1.   

Abstract

OBJECTIVE: To investigate the inflammation grading of 131I radioiodine-induced sialadenitis based upon sialoendoscopic and sialographic appearances, and to evaluate the results of sialoendoscopic intervention.
METHODS: The patients diagnosed with 131I radioiodine-induced sialadenitis and underwent sialoendoscopic exploration and intervention procedures in Peking University Hospital of Stomatology from Nov. 2012 to Oct. 2018 were included in this study. The appearances of sialogaphy and sialoendoscopy were analyzed and classified. The treatment options included irrigation with saline and dexamethasone and mechanical dilatation by sialoendoscope. The patients were followed up after treatment.
RESULTS: Forty-two patients with 131I radioiodine-induced sialadenitis were included. There were 5 males and 37 females, with a male-to-female ratio of 1 ∶7.4. Symptoms included recurrent swelling and pain in the parotid glands, and dry mouth. Sialography showed stenosis in the main duct,and in some cases nonvisua-lization of the branches. Sialoendoscopy showed narrowing of the main duct, and the branch duct atresia was seen. The appearances of sialogaphy and sialoendoscopy were analyzed and classified into 3 groups: (1) Mild inflammation: stenosis and ectasia occurred in the main duct, whereas the 0.9 mm sialoendoscope could pass through easily. (2) Moderate inflammation: one point of severe stricture could be seen in the main duct where 0.9 mm sialoendoscope could not be passed through. (3) Severe inflammation: two points or more of severe strictures or diffused strictures occurred in the main duct. Thirty-three patients with 65 affected glands were examined by both sialography and sialoendoscopy. Eight glands were classified as mild inflammation, 23 glands moderate inflammation, and 34 glands severe inflammation. The duration of follow-up ranged from 3-72 months. The clinical results were evaluated as good in 22 glands, fair in 22 glands, and poor in 19 glands, with an overall effective rate of 69.8% (44/63).
CONCLUSION: The clinical, sialographic and sialoendoscopic appearances of 131I radioiodine-induced sialadenitis showed their characteristics. We proposed an inflammation grading standard for the 131I radioiodine-induced sialadenitis based on the appearances of sialography and sialoendoscopy. Sialoendoscopy can significantly alleviate the clinical symptoms, which is an effective therapy, and better for early lesions.

Entities:  

Keywords:  Diagnosis; Iodine radioisotopes; Sialadenitis; Sialoendoscopy; Treatment outcome

Mesh:

Substances:

Year:  2020        PMID: 32541997      PMCID: PMC7433437          DOI: 10.19723/j.issn.1671-167X.2020.03.029

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  14 in total

1.  Quantification of salivary gland function in thyroid cancer patients treated with radioiodine.

Authors:  B L Malpani; A M Samuel; S Ray
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-06-01       Impact factor: 7.038

Review 2.  Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.

Authors:  B Jarzab; D Handkiewicz-Junak; J Wloch
Journal:  Endocr Relat Cancer       Date:  2005-12       Impact factor: 5.678

3.  Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.

Authors:  Ju-qing Wu; Hui-juan Feng; Wei Ouyang; Yun-gang Sun; Pan Chen; Jing Wang; Jia-lang Xian; Liu-hua Huang
Journal:  Nucl Med Commun       Date:  2015-08       Impact factor: 1.690

4.  Therapeutic sialendoscopy for the management of radioiodine sialadenitis.

Authors:  Brandon L Prendes; Lisa A Orloff; David W Eisele
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-01

Review 5.  Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know.

Authors:  Mohammad Javed Ali
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2016 Jul-Aug       Impact factor: 1.746

Review 6.  The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer.

Authors:  Douglas Van Nostrand
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

7.  Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma.

Authors:  Sophia Ish-Shalom; Lena Durleshter; Elena Segal; Rafael M Nagler
Journal:  Eur J Endocrinol       Date:  2008-05       Impact factor: 6.664

8.  Sialoendoscopy: a viable treatment for I(131) induced sialoadenitis.

Authors:  R De Luca; A Vicidomini; M Trodella; G Tartaro; G Colella
Journal:  Br J Oral Maxillofac Surg       Date:  2014-06-02       Impact factor: 1.651

9.  Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment.

Authors:  Alejandra E Geres; Paula Szafryk Mereshian; Silvia Fernández; Daniel Gonzalo Rey Caro; Ricardo Castro; Ricardo Podio; Silvia Ojeda
Journal:  Endocrinol Nutr       Date:  2015-10-12

10.  A Functional Scoring System Based on Salivary Gland Scintigraphy for Evaluating Salivary Gland Dysfunction Secondary to 131I therapy in Patients with Differentiated Thyroid Carcinoma.

Authors:  Yasuhiro Maruoka; Shingo Baba; Takuro Isoda; Yoshiyuki Kitamura; Koichiro Abe; Masayuki Sasaki; Hiroshi Honda
Journal:  J Clin Diagn Res       Date:  2017-08-01
View more
  1 in total

1.  [Studies on newly recognized chronic sialadenitis].

Authors:  G Y Yu; D G Liu; W Li; X Hong; Y Y Zhang; W X Zhu; K F Zhang; X Li; Z G Li; Y Y Liu; Y Chen; Y Gao; J Z Su
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.